BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30775878)

  • 1. A Myelodysplastic Syndrome with Concurrent Basophilia and Eosinophilia Lacking Oncogenic Mutations in 54 Relevant Genes.
    Kim M; Zang DY; Han B; Lee J; Chung Y; Park CJ; Lee YK
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia.
    Matsushima T; Handa H; Yokohama A; Nagasaki J; Koiso H; Kin Y; Tanaka Y; Sakura T; Tsukamoto N; Karasawa M; Itoh K; Hirabayashi H; Sawamura M; Shinonome S; Shimano S; Miyawaki S; Nojima Y; Murakami H
    Blood; 2003 May; 101(9):3386-90. PubMed ID: 12506028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythemia].
    Iizuka H; Yoshimi A; Yamamoto G; Masuda A; Nannya Y; Ichikawa M; Yatomi Y; Kurokawa M
    Rinsho Ketsueki; 2013 May; 54(5):468-72. PubMed ID: 23727686
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Yin CC; Tam W; Walker SM; Kaur A; Ouseph MM; Xie W; K Weinberg O; Li P; Zuo Z; Routbort MJ; Chen S; Medeiros LJ; George TI; Orazi A; Arber DA; Bagg A; Hasserjian RP; Wang SA
    Haematologica; 2024 Jun; 109(6):1825-1835. PubMed ID: 37981812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: the clinical and pathologic spectrum.
    Washington LT; Doherty D; Glassman A; Martins J; Ibrahim S; Lai R
    Leuk Lymphoma; 2002 Apr; 43(4):761-5. PubMed ID: 12153162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FISH investigation of 5q and 7q deletions in MDS/AML reveals hidden translocations, insertions and fragmentations of the same chromosomes.
    Lessard M; Herry A; Berthou C; Léglise MC; Abgrall JF; Morice P; Flandrin G
    Leuk Res; 1998 Apr; 22(4):303-12. PubMed ID: 9669835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
    Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome.
    Kantarjian HM; O'Brien S; Shan J; Aribi A; Garcia-Manero G; Jabbour E; Ravandi F; Cortes J; Davisson J; Issa JP
    Cancer; 2007 Jan; 109(2):265-73. PubMed ID: 17133405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myelodysplastic syndrome associated with marked eosinophilia and basophilia].
    Tanabe J; Sasaki S; Tamura T; Okamoto R; Sugamura R; Fujita H; Fukawa H; Kanamori H; Matsuzaki M; Mohri H
    Rinsho Ketsueki; 1992 Feb; 33(2):189-93. PubMed ID: 1635167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Overt leukemia from MDS associated with marked basophilia].
    Shirakawa C; Ohno M; Sugishima H; Morita S; Masaki H; Fujimoto T; Maeda Y; Irimajiri K; Horiuchi A
    Rinsho Ketsueki; 1992 Aug; 33(8):1031-5. PubMed ID: 1404858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes.
    Wimazal F; Germing U; Kundi M; Noesslinger T; Blum S; Geissler P; Baumgartner C; Pfeilstoecker M; Valent P; Sperr WR
    Cancer; 2010 May; 116(10):2372-81. PubMed ID: 20209617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hematologic improvement by alpha-interferon in a case of the 5q- syndrome with basophilia and eosinophilia].
    Saigo K; Sugimoto T; Ryo R; Yamaguchi N
    Rinsho Ketsueki; 1995 Jan; 36(1):18-22. PubMed ID: 7715073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated isochromosome 17q in myelodysplastic syndromes with pure red cell aplasia and basophilia.
    Inui Y; Yamamoto K; Okamura A; Yakushijin K; Hayashi Y; Matsuoka H; Minami H
    Intern Med; 2012; 51(12):1579-84. PubMed ID: 22728494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilia in myelodysplastic syndrome with a (12;21)(q23;q22) translocation.
    Kobayashi H; Kitano K; Shimodaira S; Ishida F; Saito H; Sonoyama M; Enokihara H; Furuta S
    Cancer Genet Cytogenet; 1993 Jul; 68(2):95-8. PubMed ID: 8353811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
    Fidler C; Watkins F; Bowen DT; Littlewood TJ; Wainscoat JS; Boultwood J
    Haematologica; 2004 Jul; 89(7):865-6. PubMed ID: 15257941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decitabine in the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes, Which Combined with Complex Karyotype Respectively.
    Gao S; Li Z; Fu JH; Hu XH; Xu Y; Jin ZM; Tang XW; Han Y; Chen SN; Sun AN; Wu DP; Qiu HY
    Asian Pac J Cancer Prev; 2015; 16(15):6627-32. PubMed ID: 26434886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
    Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
    Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia.
    Tibes R; Al-Kali A; Oliver GR; Delman DH; Hansen N; Bhagavatula K; Mohan J; Rakhshan F; Wood T; Foran JM; Mesa RA; Bogenberger JM
    J Hematol Oncol; 2015 Oct; 8():114. PubMed ID: 26483188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.